Kenya Pharmaceuticals and Healthcare Report Q4 2016

Publisher Name :
Date: 31-Aug-2016
No. of pages: 87

BMI View: It is vital that companies that are looking to sell non-communicable disease therapeutics work

alongside the public sector and focus on physician education and patient awareness in a market that has

traditionally focussed on infectious diseases such as malaria, tuberculosis and HIV. Besides challenges

related to diagnosis, care and treatment, there is a lack of understanding and knowledge about diseases

such as diabetes and cardiovascular disease among healthcare professionals and the general population,

and a perception that such diseases are not as critical as other diseases affecting the country.

Headline Expenditure Projections

? Pharmaceuticals: KES73.34bn (USD750mn) in 2015 to KES84.04bn (USD830mn) in 2016; 14.6%

growth in local currency terms and 10.8% in US dollar terms.

? Healthcare: KES341.18bn (USD3.47bn) in 2015 to KES377.30 (USD3.71bn) in 2016; 10.6% growth in

local currency terms and 7.0% in US dollar terms.

Kenya Pharmaceuticals and Healthcare Report Q4 2016

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Kenya 2014-2020) 7
SWOT 9
Industry Forecast 10
Pharmaceutical Market Forecast 10
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kenya 2012-2020) 11
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2012-2020) 14
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2012-2020) 15
Prescription Drug Market Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kenya 2012-2020) 17
Patented Drug Market Forecast 18
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kenya 2012-2020) 19
Generic Drug Market Forecast 20
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kenya 2012-2020) 21
OTC Medicines Market Forecast 22
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kenya 2012-2020) 23
Pharmaceutical Trade Forecast 24
Table: Pharmaceutical Trade Data And Forecasts (Kenya 2014-2020) 25
Table: Pharmaceutical Trade Data And Forecasts local currency (Kenya 2014-2020) 26
Industry Risk Reward Index 27
Middle East and Africa Risk/Reward Index - Q4 2016 27
Kenya Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Intellectual Property Issues 38
Pricing & Reimbursement Regime 38
Market Overview 40
Healthcare Sector 40
Table: Healthcare Resources (Kenya 2010-2015) 42
Table: Healthcare Personnel (Kenya 2010-2015) 42
Table: Healthcare Activity (Kenya 2010-2015) 43
Research & Development 50
Clinical Trials 52
Epidemiology 54
Competitive Landscape 57
Research-Based Industry 57
Table: Multinational Market Activity 59
Pharmaceutical Distribution 60
Pharmaceutical Retail Sector 62
Company Profile 63
GlaxoSmithKline 63
Merck & Co 66
Novartis 68
Pfizer 71
Sanofi 74
Demographic Forecast 76
Table: Population Headline Indicators (Kenya 1990-2025) 77
Table: Key Population Ratios (Kenya 1990-2025) 77
Table: Urban/Rural Population & Life Expectancy (Kenya 1990-2025) 78
Table: Population By Age Group (Kenya 1990-2025) 78
Table: Population By Age Group % (Kenya 1990-2025) 79
Glossary 81
Methodology 83
Pharmaceutical Expenditure Forecast Model 83
Healthcare Expenditure Forecast Model 83
Notes On Methodology 84
Risk/Reward Index Methodology 85
Index Overview 86
Table: Pharmaceutical Risk/Reward Index Indicators 86
Indicator Weightings 87

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (Kenya 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kenya 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2012-2020)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kenya 2012-2020)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kenya 2012-2020)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kenya 2012-2020)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kenya 2012-2020)
Table: Pharmaceutical Trade Data And Forecasts (Kenya 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Kenya 2014-2020)
Table: Healthcare Resources (Kenya 2010-2015)
Table: Healthcare Personnel (Kenya 2010-2015)
Table: Healthcare Activity (Kenya 2010-2015)
Table: Multinational Market Activity
Table: Population Headline Indicators (Kenya 1990-2025)
Table: Key Population Ratios (Kenya 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Kenya 1990-2025)
Table: Population By Age Group (Kenya 1990-2025)
Table: Population By Age Group % (Kenya 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa
    Published: 06-Dec-2016        Price: US 1995 Onwards        Pages: 240
    GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in South Africa. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure.......
  • Israel Pharmaceuticals and Healthcare Report Q1 2017
    Published: 30-Nov-2016        Price: US 1295 Onwards        Pages: 118
    BMI View: Israel will continue to be targeted by multinational drugmakers as a destination for innovative drug sales; however, their relative success will be limited by funding constraints towards the country's health services basket and the lack of transparency with new drug inclusions. An uptick in economic growth and an increase to government funding supports our moderate growth outlook for Israel's pharmaceuticals and healthcare sectors over the coming years. He......
  • Italy Pharmaceuticals and Healthcare Report Q1 2017
    Published: 30-Nov-2016        Price: US 1295 Onwards        Pages: 80
    BMI View: The rising demand for medicines for the treatment of cardiovascular diseases, gastric conditions, the nervous system and the respiratory system (the therapeutic areas that recorded the highest expenditure in 2015) and the government's aim in ensuring its population continues to access these medicines, will lead to complex pricing and reimbursement discussions, placing downward pressures on drugmaker revenue streams. Despite a long-term decline in the public expe......
  • Jordan Pharmaceuticals and Healthcare Report Q1 2017
    Published: 30-Nov-2016        Price: US 1295 Onwards        Pages: 84
    BMI View: Growth within Jordan's pharmaceutical market will be supported by a growing network of trade agreements and entry into new export markets. As a fall in domestic demand prompts expansion strategies, Jordanian drugmakers will continue to explore commercial opportunities outside of the traditional Middle Eastern pharmaceutical markets. The strengthening of pre-existing ties will support local drugmakers' attempts to boost their export potential and further trade wi......
  • Lebanon Pharmaceuticals and Healthcare Report Q1 2017
    Published: 30-Nov-2016        Price: US 1295 Onwards        Pages: 77
    BMI View: The ongoing Syrian civil war has had a substantial impact on Lebanon's healthcare service and finances, with a troubled political climate further exacerbating the crisis. On a positive note, the influx of international funds to help with the country's refugee surge has led to an increase in primary healthcare centres opening, providing greater access to the country's most vulnerable people. Over the long term, we expect a growing and ageing population, coupled w......
  • Mauritius Pharmaceuticals and Healthcare Report Q1 2017
    Published: 30-Nov-2016        Price: US 1295 Onwards        Pages: 53
    BMI View: Healthcare spending growth and a business-friendly policy environment will continue to create commercial opportunities for drugmakers and healthcare operators in Mauritius over the forecast period. Meanwhile, the outlook for a stronger integration between Mauritius and regional peers including India, Pakistan and the East African Community bodes well for Mauritius' efforts to gradually strengthen its position as a biomedicine manufacturing hub and medical touris......
  • Philippines Pharmaceuticals and Healthcare Report Q1 2017
    Published: 30-Nov-2016        Price: US 1295 Onwards        Pages: 98
    BMI View: Despite high enrolment numbers with the Philippine Health Insurance Corporation (PhilHealth), further reforms to the Philippines's healthcare system will be necessary for the country's universal healthcare scheme to galvanise the pharmaceutical and healthcare sector. Factors such as a lack of human resources, poor patient accessibility to clinics and hospitals and limited insurance coverage will all hold back growth in the healthcare sector. Headline Expen......
  • Poland Pharmaceuticals and Healthcare Report Q1 2017
    Published: 30-Nov-2016        Price: US 1295 Onwards        Pages: 73
    BMI View: The outlook for both Poland's pharmaceutical and healthcare markets will be driven by government reforms targeting greater access to healthcare. Over the short term, changes to reimbursement and co-payment exemptions will boost expenditure, while the change to a tax-based healthcare system will drive long-term growth. Headline Expenditure Projections ? Pharmaceuticals: PLN33.39bn (USD8.86bn) in 2015 to PLN34.79bn (USD8.56bn) in 2016; +4.2% in local c......
  • Romania Pharmaceuticals and Healthcare Report Q1 2017
    Published: 30-Nov-2016        Price: US 1295 Onwards        Pages: 78
    BMI View: In line with Romania's economic outperformance in Europe, the country's pharmaceutical and healthcare markets will see strong growth given increased consumer spending power and higher healthcare contributions. However, aggressive drug pricing regulations and cross-border negotiations on medicine pricing and procurement will limit revenue-earning opportunities. Headline Expenditure Projections ? Pharmaceuticals: RON14.94bn (USD3.73bn) in 2015 to RON15.90bn ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs